Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exogenous and endogenous toxins represent a broad category of deleterious substances that disrupt physiological homeostasis and drive the progression of numerous diseases. Exogenous toxins, or xenobiotics, include environmental pollutants, heavy metals, drugs, and bacterial exotoxins that enter the body from external sources. Endogenous toxins are harmful products generated internally, such as reactive oxygen species (ROS), metabolic waste products like urea and ammonia, and excessively produced cytokines during systemic inflammatory responses. These substances contribute to pathologies including chemical atherogenesis, acute kidney injury, neurodegeneration, and sepsis by inducing oxidative stress and activating chronic inflammatory cascades. Therapeutic approaches to manage these toxins focus on neutralization through pharmacological antidotes, enhancement of metabolic detoxification pathways, or physical removal via extracorporeal blood purification technologies. Because this term encompasses a vast and chemically diverse group of molecules rather than a single specific receptor or enzyme, it is classified as a broad clinical and toxicological category.
Drugs and medical devices targeting these substances operate through physical adsorption, chemical chelation, enzymatic neutralization, or the augmentation of endogenous antioxidant systems to mitigate systemic toxicity and prevent organ damage.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exogenous and Endogenous Toxins.